Citation Impact
Citing Papers
Comparison of Effects of the Bisphosphonate Alendronate Versus the RANKL Inhibitor Denosumab on Murine Fracture Healing
2008
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Adverse metabolic and cardiovascular consequences of circadian misalignment
2009 Standout
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
2008
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
TOR Signaling in Growth and Metabolism
2006 Standout
Inflammation-Induced Bone Loss: Can it Be Prevented?
2006
Design of effective immunotherapy for human autoimmunity
2005 Nature
Osteoporosis
2019 Standout
Adiponectin protects against cerebral ischemia–reperfusion injury through anti-inflammatory action
2009 StandoutNobel
Leptin revisited: its mechanism of action and potential for treating diabetes
2012
Challenges and Opportunities of Defining Clinical Leptin Resistance
2012
Identification and Importance of Brown Adipose Tissue in Adult Humans
2009 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial
2008
Cancer to bone: a fatal attraction
2011 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Cytokine networks—towards new therapies for rheumatoid arthritis
2005
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Kisspeptins: Bridging energy homeostasis and reproduction
2010
Treatment of Obesity with Celastrol
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Adipokines in Obesity
2008
Cancer immunotherapy via dendritic cells
2012 Standout
Osteoporosis: now and the future
2011 Standout
Independent Circadian and Sleep/Wake Regulation of Adipokines and Glucose in Humans
2005
Treatment of osteoporosis with denosumab
2010
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Delivery technologies for cancer immunotherapy
2019 Standout
Skeletal remodeling in health and disease
2007 Standout
Leptin for type 1 diabetes: coming onto stage to be (or not?)
2011
Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates
2005
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Advances in osteoclast biology: old findings and new insights from mouse models
2011
Small Differences in Thyroid Function May Be Important for Body Mass Index and the Occurrence of Obesity in the Population
2005
Hypercalcemia Associated with Cancer
2005
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells
2007 Standout
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
2011
Biomedical applications of bisphosphonates
2013
Denosumab in Postmenopausal Women with Low Bone Mineral Density
2006
Graves' Ophthalmopathy
2010 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab
2013
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
2009
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
2005
Brain regulation of food intake and appetite: molecules and networks
2005
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Type 1 diabetes
2013 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Leptin at 14 y of age: an ongoing story
2009
Rheumatoid arthritis
2010 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target
2013 Standout
What We Talk About When We Talk About Fat
2014 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
On the mechanisms of biocompatibility
2008 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Leptin in human physiology and therapeutics
2010
Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications
2006
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Leptin in humans: lessons from translational research
2009
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
2008
RANKL Inhibition: From Mice to Men (and Women)
2007
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
2017
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Obesity and leptin resistance: distinguishing cause from effect
2010
Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases
2004
Adipose Tissue as an Endocrine Organ
2004 Standout
The Cellular and Molecular Biology of Periprosthetic Osteolysis
2006
Denosumab and bisphosphonates: Different mechanisms of action and effects
2010
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
The Geometry of Leptin Action in the Brain: More Complicated Than a Simple ARC
2009
Leptin is an effective treatment for hypothalamic amenorrhea
2011
Regulation of Thyrotropin-Releasing Hormone-Expressing Neurons in Paraventricular Nucleus of the Hypothalamus by Signals of Adiposity
2010
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure
2009
Minireview: CNS Mechanisms of Leptin Action
2015
Caloric Restriction Decreases Cortical Bone Mass but Spares Trabecular Bone in the Mouse Skeleton: Implications for the Regulation of Bone Mass by Body Weight
2008
Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD
2007
How Obesity Causes Diabetes: Not a Tall Tale
2005 Science
Endocrine Manifestations of Eating Disorders
2010
Thyroid Hormone Regulation of Metabolism
2014 Standout
Thyroid Hormones and the Metabolic Syndrome
2013
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
2009 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Multiple Myeloma
2011 Standout
Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
2009
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
2008
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
2013
Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases
2007
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
2008
Works of Robyn Murphy being referenced
Recombinant Human Leptin in Women with Hypothalamic Amenorrhea
2004
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2004
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2005
Recombinant Human Leptin in Women With Hypothalamic Amenorrhea
2005